TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 52 filers reported holding TALARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,714 | -30.9% | 36,197 | -25.2% | 0.00% | – |
| Q2 2023 | $147,120 | -71.5% | 48,395 | -82.4% | 0.00% | – |
| Q1 2023 | $516,314 | +3695.9% | 274,635 | +1959.4% | 0.00% | – |
| Q4 2022 | $13,602 | -73.3% | 13,336 | -30.5% | 0.00% | – |
| Q3 2022 | $51,000 | -50.5% | 19,189 | -15.5% | 0.00% | – |
| Q2 2022 | $103,000 | -69.4% | 22,697 | -33.7% | 0.00% | – |
| Q1 2022 | $337,000 | -34.1% | 34,218 | +2.2% | 0.00% | – |
| Q4 2021 | $511,000 | +58.2% | 33,473 | +40.4% | 0.00% | – |
| Q3 2021 | $323,000 | +20.1% | 23,845 | +30.6% | 0.00% | – |
| Q2 2021 | $269,000 | – | 18,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |